Health Care & Life Sciences » Biotechnology | CTI BioPharma Corp.

CTI BioPharma Corp.

CTI BioPharma Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.63
Market Cap
$47.22 M
Shares Outstanding
57.98 M
Public Float
53.5 M

Profile

Address
3101 Western Avenue
Seattle Washington 98121
United States
Employees -
Website http://www.ctibiopharma.com
Updated 07/08/2019
CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A.

Financials

View All

Laurent Fischer
Chairman
Adam R. Craig
President, Chief Executive Officer & Director